Daesung Microbiological Labs. Co. Ltd Logo

Daesung Microbiological Labs. Co. Ltd

Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.

036480 | KO

Overview

Corporate Details

ISIN(s):
KR7036480002
LEI:
Country:
South Korea
Address:
경기도 의왕시 덕영대로 103, 의왕시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daesung Microbiological Labs. Co., Ltd. is a veterinary pharmaceutical company engaged in the research, manufacture, and sale of animal medicines. Established in 1968, the company has over half a century of experience contributing to the health of the livestock industry. Its product portfolio includes a wide range of vaccines, antibiotics, and other therapeutic drugs for various animals, including swine, poultry, cattle, canines, and fish. As a leading vaccine manufacturer with KGMP (Korean Good Manufacturing Practice) certification, the company focuses on producing high-quality products aimed at disease prevention and promoting animal welfare.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 749.2 KB
2025-06-26 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.1 KB
2025-06-23 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.1 KB
2025-05-26 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.5 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 756.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.7 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 18.8 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 928.0 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 120.2 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.2 KB
2025-02-11 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.8 KB
2025-02-11 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.8 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-13 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 653.8 KB
2024-08-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.9 KB

Automate Your Workflow. Get a real-time feed of all Daesung Microbiological Labs. Co. Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Daesung Microbiological Labs. Co. Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Daesung Microbiological Labs. Co. Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ANAVEX LIFE SCIENCES CORP. Logo
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America
ANEB
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan
4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden
ANNX
Annexon, Inc. Logo
Developing C1q inhibitors for autoimmune, neurodegenerative, and ophthalmic diseases.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea
065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania
ATB

Talk to a Data Expert

Have a question? We'll get back to you promptly.